{"id":744,"date":"2024-03-04T18:05:12","date_gmt":"2024-03-05T02:05:12","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?p=744"},"modified":"2024-03-21T21:39:22","modified_gmt":"2024-03-22T04:39:22","slug":"cbt-004-has-completed-the-first-patient-in-for-phase-ii-clinical-trials-in-the-us","status":"publish","type":"post","link":"https:\/\/cloudbreakpharma.com\/zh\/cbt-004-has-completed-the-first-patient-in-for-phase-ii-clinical-trials-in-the-us\/","title":{"rendered":"CBT-004\u5df2\u5728\u7f8e\u56fd\u5b8c\u6210\u4e34\u5e8a2\u671f\u7684\u9996\u4f4d\u75c5\u4eba\u5165\u7ec4"},"content":{"rendered":"<p>\u6211\u4eec\u5f88\u81ea\u8c6a\u5730\u5ba3\u5e03\uff0cCBT-004 \u662f\u4e00\u79cd\u6f5c\u5728\u7684\u8840\u7ba1\u5316\u7773\u5b54\u836f\u7269\uff0c\u5df2\u4e8e 2023 \u5e74 12 \u6708\u5728\u7f8e\u56fd\u5b8c\u6210\u4e34\u5e8a2\u671f\u7684\u9996\u4f4d\u60a3\u8005\u5165\u7ec4\u3002<\/p>\n<p>\u5145\u8840\u6027\u7ed3\u819c\u9ec4\u6591\u662f\u4e00\u79cd\u5706\u5f62\u3001\u6de1\u9ec4\u8272\u7684\u9686\u8d77\u7ec4\u7ec7\uff0c\u957f\u5728\u89d2\u819c\u9644\u8fd1\u7684\u7ed3\u819c\u4e0a\uff0c\u7d2b\u5916\u7ebf\u7684\u7d2f\u79ef\u7167\u5c04\u662f\u5bfc\u81f4\u5145\u8840\u6027\u7ed3\u819c\u9ec4\u6591\u7684\u4e3b\u8981\u539f\u56e0\u3002 \u4e00\u822c\u800c\u8a00\uff0c\u65e0\u75c7\u72b6\u7684\u7751\u88c2\u6591\u65e0\u9700\u6cbb\u7597\uff0c\u4f46\u5176\u6de1\u9ec4\u8272\u548c\u9686\u8d77\u7684\u8f6e\u5ed3\u53ef\u80fd\u4f1a\u5f15\u8d77\u673a\u68b0\u6027\u6216\u4e0e\u6cea\u819c\u4e0d\u826f\u6709\u5173\u7684\u773c\u8868\u523a\u6fc0\u3002 \u5f53\u75c5\u53d8\u90e8\u4f4d\u8840\u7ba1\u5316\u53ca\u2571\u6216\u53d1\u708e\u65f6\uff0c\u53ef\u80fd\u4f1a\u5bfc\u81f4\u773c\u90e8\u5145\u8840\u3001\u4e0d\u9002\u3001\u75bc\u75db\u3001\u5f02\u7269\u611f\u3001\u6d41\u6cea\u548c\u75d5\u75d2\u7b49\u75c7\u72b6\u3002<\/p>\n<p>\u6839\u636e\u5f17\u82e5\u65af\u7279\u6c99\u5229\u6587\u62a5\u544a\uff0c\u76ee\u524d\u5168\u7403\u5e76\u65e0\u83b7\u6279\u7684\u836f\u7269\u7528\u6765\u6cbb\u7597\u5145\u8840\u6027\u7ed3\u819c\u9ec4\u6591\u3002 \u800c\u5728\u5168\u7403\u8303\u56f4\u5185\uff0c2022\u5e74\u7ed3\u819c\u9ec4\u6591\u60a3\u8005\u4eba\u6570\u8fbe\u523011.496\u4ebf\uff0c2018\u5e74\u81f32022\u5e74\u590d\u5408\u5e74\u589e\u957f\u7387\u4e3a1.2%\u3002 \u9884\u8ba12027\u5e74\u5c06\u8fbe\u523012.171\u4ebf\uff0c2032\u5e74\u5c06\u8fbe\u523012.838\u4ebf\uff0c2022\u5e74\u52302027\u5e74\u590d\u5408\u5e74\u589e\u957f\u7387\u4e3a1.1% \uff0c2027\u5e74\u52302032\u5e74\u590d\u5408\u589e\u957f\u7387\u4e3a1.1%\u3002<\/p>\n<p>CBT-004\u662f\u4e00\u79cd\u6f5c\u5728\u7684\u56fd\u9645\u540c\u7c7b\u9996\u521b\u773c\u79d1\u65b0\u836f\uff0c\u91c7\u7528\u7a81\u7834\u6027\u591a\u6fc0\u9176\u6291\u5236\u5242\uff0c\u9776\u5411\u8840\u7ba1\u5185\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\u53ca\u8840\u5c0f\u677f\u884d\u751f\u751f\u957f\u56e0\u5b50\u53d7\u4f53\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>We are proud to announce that CBT-004, a potential first-in-class drug for vascularised pinguecula, has completed the first patient-in for Phase 2 clinical trials in December 2023 in the US. Pinguecula is a round, yellowish, elevated tissue that develops on the conjunctiva adjacent to the cornea. Cumulative exposure to UV light is the main cause [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/posts\/744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/comments?post=744"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/posts\/744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/media\/736"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/media?parent=744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/categories?post=744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/tags?post=744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}